相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Mechanisms Leading to Differential Hypoxia-Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
Milton Packer
AMERICAN JOURNAL OF KIDNEY DISEASES (2021)
Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function
Volker Vallon et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 83 (2021)
Consensus-based technical recommendations for clinical translation of renal BOLD MRI
Octavia Bane et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2020)
Consensus-based technical recommendations for clinical translation of renal T1 and T2 mapping MRI
Ilona A. Dekkers et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2020)
Consensus-based technical recommendations for clinical translation of renal ASL MRI
Fabio Nery et al.
MAGNETIC RESONANCE MATERIALS IN PHYSICS BIOLOGY AND MEDICINE (2020)
The role of renal hypoxia in the pathogenesis of diabetic kidney disease: a promising target for newer renoprotective agents including SGLT2 inhibitors?
Anne C. Hesp et al.
KIDNEY INTERNATIONAL (2020)
Relative Hypoxia and Early Diabetic Kidney Disease in Type 1 Diabetes
Carissa Vinovskis et al.
DIABETES (2020)
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo-Controlled Trial
Anne Zanchi et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Dapagliflozin in Patients with Chronic Kidney Disease
Hiddo J. L. Heerspink et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Circadian variation in renal blood flow and kidney function in healthy volunteers monitored with noninvasive magnetic resonance imaging
Per Eckerbom et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2020)
Acute hyperglycemia increases renal tissue oxygenation as measured by BOLD-MRI in healthy overweight volunteers
Nima Vakilzadeh et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2019)
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
V. Perkovic et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Impact of Sotagliflozin on Renal Function, Albuminuria, Blood Pressure, and Hematocrit in Adults With Type 1 Diabetes
Daniel H. van Raalte et al.
DIABETES CARE (2019)
CONSORT 2010 statement: extension to randomised crossover trials
Kerry Dwan et al.
BMJ-BRITISH MEDICAL JOURNAL (2019)
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis
Brendan L. Neuen et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
Ryoichi Bessho et al.
SCIENTIFIC REPORTS (2019)
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
S. D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks
Simeon I. Taylor et al.
LANCET DIABETES & ENDOCRINOLOGY (2019)
Renoprotective effects of sodium-glucose cotransporter-2 inhibitors
Hiddo J. L. Heerspink et al.
KIDNEY INTERNATIONAL (2018)
Reduced cortical oxygenation predicts a progressive decline of renal function in patients with chronic kidney disease
Menno Pruijm et al.
KIDNEY INTERNATIONAL (2018)
Assessment of Perfusion and Oxygenation of the Human Renal Cortex and Medulla by Quantitative MRI during Handgrip Exercise
Bryan Thomas Haddock et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2018)
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes
Bruce Neal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Sodium-Glucose Cotransporter 2 Inhibitors with Renoprotective Effects
Bancha Satirapoj
KIDNEY DISEASES (2017)
Prevalence and co-prevalence of comorbidities among patients with type 2 diabetes mellitus
Kristy Iglay et al.
CURRENT MEDICAL RESEARCH AND OPINION (2016)
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Christoph Wanner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients
Aki Okamoto et al.
DRUGS IN R&D (2016)
Acute SGLT inhibition normalizes O-2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats
Julie O'Neill et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2015)
Renal Hemodynamic Effect of Sodium-Glucose Cotransporter 2 Inhibition in Patients With Type 1 Diabetes Mellitus
David Z. I. Cherney et al.
CIRCULATION (2014)
Clinical Pharmacokinetics and Pharmacodynamics of Dapagliflozin, a Selective Inhibitor of Sodium-Glucose Co-transporter Type 2
Sreeneeranj Kasichayanula et al.
CLINICAL PHARMACOKINETICS (2014)
Determinants of Renal Tissue Oxygenation as Measured with BOLD-MRI in Chronic Kidney Disease and Hypertension in Humans
Menno Pruijm et al.
PLOS ONE (2014)
Homogenous 96-Plex PEA Immunoassay Exhibiting High Sensitivity, Specificity, and Excellent Scalability
Erika Assarsson et al.
PLOS ONE (2014)
Imaging of intrarenal haemodynamics and oxygen metabolism
Per Liss et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2013)
Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells-Renoprotection in Diabetic Nephropathy?
Usha Panchapakesan et al.
PLOS ONE (2013)
Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI
Wen-Jie Yin et al.
EUROPEAN JOURNAL OF RADIOLOGY (2012)
Short-term oxygen administration restores blunted baroreflex sensitivity in patients with type 1 diabetes
L. Bernardi et al.
DIABETOLOGIA (2011)
Glucose handling by the kidney
Amanda Mather et al.
KIDNEY INTERNATIONAL (2011)
Dapagliflozin Monotherapy in Type 2 Diabetic Patients With Inadequate Glycemic Control by Diet and Exercise A randomized, double-blind, placebo-controlled, phase 3 trial
Ele Ferrannini et al.
DIABETES CARE (2010)
Effect of Sodium Loading/Depletion on Renal Oxygenation in Young Normotensive and Hypertensive Men
Menno Pruijm et al.
HYPERTENSION (2010)
Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects
B. Komoroski et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes
James F. List et al.
DIABETES CARE (2009)
Validation of quantitative BOLD MRI measurements in kidney:: Application to unilateral ureteral obstruction
M Pedersen et al.
KIDNEY INTERNATIONAL (2005)
Blood oxygen level-dependent measurement of acute intra-renal ischemia
L Juillard et al.
KIDNEY INTERNATIONAL (2004)
分享论文
